Edesa Biotech (EDSA) News Today → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free EDSA Stock Alerts $4.33 -0.07 (-1.59%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 30 at 6:02 AM | americanbankingnews.comEdesa Biotech, Inc. (NASDAQ:EDSA) to Post FY2024 Earnings of ($1.95) Per Share, Zacks Small Cap ForecastsMay 28, 2024 | finance.yahoo.comEDSA: Preparing IND for Phase 2 Trial of EB06 in VitiligoMay 10, 2024 | investorplace.comEDSA Stock Earnings: Edesa Biotech Beats EPS for Q2 2024March 26, 2024 | insidertrades.comInsider Buying: Edesa Biotech, Inc. (NASDAQ:EDSA) CEO Acquires 5,000 Shares of StockFebruary 15, 2024 | finance.yahoo.comEDSA: Development of EB05 in ARDS Continues…February 14, 2024 | investing.comEdesa Biotech Inc (EDSA)February 11, 2024 | benzinga.comEdesa Biotech Stock (NASDAQ:EDSA) Earnings Dates and Earning CallsFebruary 9, 2024 | finance.yahoo.comEdesa Biotech Reports Fiscal 1st Quarter 2024 ResultsJanuary 2, 2024 | finance.yahoo.comEDSA: Updated Phase 3 Protocol for EB05 Trial Approved by Canadian Regulators…December 15, 2023 | finance.yahoo.comEdesa Biotech Reports Fiscal Year 2023 ResultsDecember 12, 2023 | marketbeat.comTrading was temporarily halted for "EDSA" at 12:12 PM with a stated reason of "LULD pause."December 1, 2023 | benzinga.comEdesa Biotech Stock (NASDAQ:EDSA) Dividends: History, Yield and DatesNovember 12, 2023 | morningstar.comEdesa Biotech Inc EDSANovember 2, 2023 | msn.comEdesa Biotech (EDSA) Price Target Increased by 528.00% to 53.38October 26, 2023 | finance.yahoo.comEdesa Biotech to Present at Dermatology Drug Development SummitOctober 25, 2023 | finance.yahoo.comRegulators Approve Updated Phase 3 Trial Design for Edesa Biotech’s ARDS DrugOctober 19, 2023 | finance.yahoo.comEDSA: Secures up to CAD$23 Million to Fund Development of EB05…October 13, 2023 | marketbeat.comTrading was temporarily halted for "EDSA" at 09:10 AM with a stated reason of "LULD pause."October 12, 2023 | msn.comWhy Is Infectious Disease Player Edesa Biotech Stock Soaring Today?October 12, 2023 | finance.yahoo.comEdesa Biotech to Receive Up To C$23 Million in Funding from Federal GovernmentOctober 12, 2023 | finance.yahoo.comEdesa Biotech Secures $10 Million Credit Facility with Company FounderOctober 12, 2023 | marketbeat.comTrading was temporarily halted for "EDSA" at 12:10 PM with a stated reason of "LULD pause."October 11, 2023 | seekingalpha.comEdesa Biotech falls after 1-for-7 reverse stock split announcementOctober 10, 2023 | marketwatch.comEdesa Biotech Falls to 52-Week Low on Reverse Split NewsOctober 10, 2023 | finance.yahoo.comEdesa Biotech Announces One-for-Seven Reverse Share SplitSeptember 28, 2023 | finance.yahoo.comEdesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug CandidateAugust 16, 2023 | finance.yahoo.comEDSA: EB05 Inhibits Inflammation Initiated by Multiple Pathogens In Vitro…August 15, 2023 | msn.comHC Wainwright & Co. Maintains Edesa Biotech (EDSA) Buy RecommendationAugust 9, 2023 | finance.yahoo.comEdesa Biotech Reports Fiscal Third Quarter 2023 ResultsJuly 27, 2023 | finance.yahoo.comEdesa Biotech to Participate in Upcoming Canaccord Genuity Growth ConferenceJune 28, 2023 | msn.comEdesa Biotech's COVID-19 Candidate Restraints Inflammation From Influenza, Other Pathogens In Preclinical StudiesJune 28, 2023 | finance.yahoo.comEdesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other PathogensJune 15, 2023 | finance.yahoo.comEdesa Biotech Anti-Inflammatory Drug Candidate Assigned NameMay 24, 2023 | msn.comHC Wainwright & Co. Reiterates Edesa Biotech (EDSA) Buy RecommendationMay 19, 2023 | investing.comEdesa Biotech (EDSA) Earnings Dates & ReportsMay 17, 2023 | finance.yahoo.comEDSA: FDA Agrees on Primary Endpoint for Phase 3 ARDS Drug Study…May 12, 2023 | msn.comEdesa Biotech GAAP EPS of -$0.12 beats by $0.05May 11, 2023 | finance.yahoo.comEdesa Biotech Reports Fiscal 2nd Quarter 2023 ResultsApril 20, 2023 | finance.yahoo.comEdesa Biotech to Participate in Swiss Biotech DayApril 4, 2023 | finanznachrichten.deEdesa Biotech: The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug CandidateApril 4, 2023 | finance.yahoo.comThe WHO and USAN Adopt Generic Name for Edesa's ARDS Drug CandidateMarch 25, 2023 | uk.finance.yahoo.comEdesa Biotech, Inc. (EDSA)March 23, 2023 | finance.yahoo.comEdesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Disease ConferenceMarch 16, 2023 | finance.yahoo.comEdesa Biotech to Present Favorable Dermatitis Drug Results at American Academy of Dermatology Association Annual MeetingMarch 16, 2023 | benzinga.comEdesa Biotech Stock (NASDAQ:EDSA), Short Interest ReportMarch 16, 2023 | benzinga.comEdesa Biotech Stock (NASDAQ:EDSA), Guidance and ForecastMarch 15, 2023 | markets.businessinsider.comH.C. Wainwright Reaffirms Their Buy Rating on Edesa Biotech (EDSA)March 15, 2023 | finance.yahoo.comEdesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug StudyFebruary 15, 2023 | finance.yahoo.comEDSA: Positive News Flow to Start 2023…February 12, 2023 | finance.yahoo.comIs Edesa Biotech (NASDAQ:EDSA) In A Good Position To Invest In Growth? Get Edesa Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for EDSA and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”. You just have to make this simple move before July 30, 2024. EDSA Media Mentions By Week EDSA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EDSA News Sentiment▼0.810.76▲Average Medical News Sentiment EDSA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EDSA Articles This Week▼70▲EDSA Articles Average Week Get Edesa Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for EDSA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PIRS News Today RDHL News Today MIRA News Today KPRX News Today PPBT News Today FLGC News Today HUGE News Today VINC News Today OGEN News Today IMNN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EDSA) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edesa Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
